These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16977919)

  • 1. Diabetes: one part of the cardiovascular problem post-transplant.
    Luxon A; First MR
    Nephrol News Issues; 2006 Sep; 20(10):33-4. PubMed ID: 16977919
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular risk in kidney transplant recipients with diabetes].
    Biancone L
    G Ital Nefrol; 2010; 27(1):5. PubMed ID: 20191451
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk factors and consequences of post-transplant diabetes mellitus.
    Demirci MS; Toz H; Yilmaz F; Ertilav M; Asci G; Ozkahya M; Zeytinoglu A; Nart D; Ok E
    Clin Transplant; 2010; 24(5):E170-7. PubMed ID: 20384711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Post-transplantation diabetes mellitus].
    Yamada K
    Nihon Jinzo Gakkai Shi; 2004; 46(8):781-8. PubMed ID: 15645733
    [No Abstract]   [Full Text] [Related]  

  • 5. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
    Sacks FM
    Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
    [No Abstract]   [Full Text] [Related]  

  • 6. New-onset diabetes after kidney transplantation: risk factors.
    Rodrigo E; Fernández-Fresnedo G; Valero R; Ruiz JC; Piñera C; Palomar R; González-Cotorruelo J; Gómez-Alamillo C; Arias M
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S291-5. PubMed ID: 17130277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients.
    Chadban S
    Nephrol Dial Transplant; 2008 Jun; 23(6):1816-8. PubMed ID: 18326882
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients.
    Kim SJ; Prasad GV; Huang M; Nash MM; Famure O; Park J; Thenganatt MA; Chowdhury N; Cole EH; Fenton SS; Cattran DC; Zaltzman JS; Cardella CJ
    Transplantation; 2006 Oct; 82(7):924-30. PubMed ID: 17038908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association.
    Marwick TH; Hordern MD; Miller T; Chyun DA; Bertoni AG; Blumenthal RS; Philippides G; Rocchini A; ; ; ; ;
    Circulation; 2009 Jun; 119(25):3244-62. PubMed ID: 19506108
    [No Abstract]   [Full Text] [Related]  

  • 10. [Post-transplant diabetes mellitus: diagnosis and treatment].
    Campise M
    G Ital Nefrol; 2007; 24(6):547-57. PubMed ID: 18278758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertension after kidney transplantation].
    Racki S
    Lijec Vjesn; 2006; 128(11-12):373-8. PubMed ID: 17212200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.
    Dennison CR; Hughes S
    J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796
    [No Abstract]   [Full Text] [Related]  

  • 13. [Increased risk of cardiovascular diseases and diabetes in mentally ill persons. Life style is a contributing factor].
    Attvall S; Eliasson B; Nilsson P
    Lakartidningen; 2003 Jul; 100(28-29):2353-5. PubMed ID: 12899026
    [No Abstract]   [Full Text] [Related]  

  • 14. Type 2 diabetes in children: a growing epidemic.
    Jones TF
    Ky Nurse; 2007; 55(4):7-8. PubMed ID: 18200782
    [No Abstract]   [Full Text] [Related]  

  • 15. Preservation of renal function and cardiovascular risk factors.
    van Hooff JP; Gelens M; Boots JM; van Duijnhoven EM; Dackus J; Christiaans MH
    Transplant Proc; 2006 Sep; 38(7):1987-91. PubMed ID: 16979974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion from cyclosporine microemulsion to tacrolimus in stable kidney transplant patients with hypercholesterolemia is related to an improvement in cardiovascular risk profile: a prospective study.
    Marcén R; Chahin J; Alarcón A; Bravo J
    Transplant Proc; 2006 Oct; 38(8):2427-30. PubMed ID: 17097957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.
    Roland M; Gatault P; Doute C; Büchler M; Al-Najjar A; Barbet C; Chatelet V; Marlière JF; Nivet H; Lebranchu Y; Halimi JM
    Transpl Int; 2008 Jun; 21(6):523-30. PubMed ID: 18266773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death.
    Aalten J; Hoogeveen EK; Roodnat JI; Weimar W; Borm GF; de Fijter JW; Hoitsma AJ
    Transpl Int; 2008 Oct; 21(10):985-91. PubMed ID: 18564985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live longer, live better: lifestyle diseases and their prevention, part 2.
    Morse DR
    Dent Today; 2006 Jul; 25(7):100, 102-3. PubMed ID: 16884080
    [No Abstract]   [Full Text] [Related]  

  • 20. [Post-transplantation diabetes mellitus].
    Moreau K
    Nephrol Ther; 2006 Jan; 2 Suppl 1():S71-6. PubMed ID: 17378145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.